TheVaccines Manufacturing and Innovation Centre (VMIC) is avaccine research and manufacturing facility under construction inHarwell Science and Innovation Campus inOxfordshire, England. Announced in December 2018[1] and originally planned to be opened in 2022,[2] its planned opening date has been brought forward to 2021 as a response to theCOVID-19 pandemic.[3]
Organizations collaborating in the centre's development includeImperial College London, theLondon School of Hygiene and Tropical Medicine, andOxford University.[2] The UK government provided funding of £93 million for the construction of the centre in 2020,[4] and by March 2021 total funding reached £215m.[5]
Construction of the 7,000 square metre facility atHarwell was begun by main contractor Glencar in April 2020.[6]
In 2020, the centre's personnel contributed to development of theOxford–AstraZeneca COVID-19 vaccine AZD1222, and from October began medium-scale production.[7]
51°42′59″N1°12′58″W / 51.7163889°N 1.2161111°W /51.7163889; -1.2161111
 | This article about an organisation in theUnited Kingdom is astub. You can help Wikipedia byexpanding it. |
 | This article about amedical,pharmaceutical orbiotechnological corporation or company is astub. You can help Wikipedia byexpanding it. |
